Article Details
Retrieved on: 2021-02-01 13:18:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... agreement under which Exelixis will utilize Adagene's SAFEbody™ technology platform to generate masked versions of monoclonal antibodies from ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here